DIFICID®

Drug Information Related Patent
Hold Company
MERCK SHARP DOHME
Learn More
Dosage and Administration
TABLET;ORAL
Specification
200MG
Indication
DIFICID® is indicated for the treatment of Clostridium Difficile-associated Diarrhea (CDAD) in adults.
Use
Instructions for Use
API
FIDAXOMICIN
API Structure
We Supply
FIDAXOMICIN
Note:

USP/EP/CP
Facility GMP
DMF/CDE

null
Note:

null

null
Note:

null

Drug Patent
Patent NoExpiration Date
73785082027/7/31
7378508*PED2028/1/31
78632492027/7/31
7863249*PED2028/1/31
79064892027/3/4
7906489*PED2027/9/4
8586551*PED2024/1/15
88595102027/7/31
8859510*PED2028/1/31
API Patent
Patent NoExpiration Date
73785082027/7/31
7378508*PED2028/1/31
78632492027/7/31
7863249*PED2028/1/31
88595102027/7/31
8859510*PED2028/1/31
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION
CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen-ING. All Rights Reserved.
dcat
Member of
dcat
Top